- Home
- BRNS vs ARQQ Comparison
BRNS vs ARQQ Comparison
Compare BRNS & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- ARQQ
- Stock Information
- Founded
- BRNS 2016
- ARQQ 2017
- Country
- BRNS United Kingdom
- ARQQ United Kingdom
- Employees
- BRNS N/A
- ARQQ N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- ARQQ Computer Software: Prepackaged Software
- Sector
- BRNS Health Care
- ARQQ Technology
- Exchange
- BRNS Nasdaq
- ARQQ Nasdaq
- Market Cap
- BRNS 41.0M
- ARQQ 282.1M
- IPO Year
- BRNS 2021
- ARQQ N/A
- Fundamental
- Price
- BRNS $1.11
- ARQQ $29.29
- Analyst Decision
- BRNS Strong Buy
- ARQQ Strong Buy
- Analyst Count
- BRNS 2
- ARQQ 1
- Target Price
- BRNS $4.00
- ARQQ $27.00
- AVG Volume (30 Days)
- BRNS 64.8K
- ARQQ 1.4M
- Earning Date
- BRNS 11-06-2024
- ARQQ 12-31-2024
- Dividend Yield
- BRNS N/A
- ARQQ N/A
- EPS Growth
- BRNS N/A
- ARQQ N/A
- EPS
- BRNS N/A
- ARQQ N/A
- Revenue
- BRNS $14,969,000.00
- ARQQ $293,000.00
- Revenue This Year
- BRNS $1,805.74
- ARQQ $3,516.04
- Revenue Next Year
- BRNS N/A
- ARQQ N/A
- P/E Ratio
- BRNS N/A
- ARQQ N/A
- Revenue Growth
- BRNS 106.21
- ARQQ N/A
- 52 Week Low
- BRNS $0.80
- ARQQ $3.72
- 52 Week High
- BRNS $4.16
- ARQQ $42.90
- Technical
- Relative Strength Index (RSI)
- BRNS 54.91
- ARQQ 56.31
- Support Level
- BRNS $0.98
- ARQQ $22.30
- Resistance Level
- BRNS $1.25
- ARQQ $42.90
- Average True Range (ATR)
- BRNS 0.14
- ARQQ 6.82
- MACD
- BRNS 0.03
- ARQQ 0.02
- Stochastic Oscillator
- BRNS 68.82
- ARQQ 31.69
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.